Bioequivalence comparison of two drug-in-adhesive transdermal nitroglycerin patches

American Journal of Therapeutics

Volumn 3, Issue 8, 1996, Pages 580-585

  Harrison, Lester I ^a   Riedel, Dianna J ^a   Machacek, Jane H ^a   Crowley, Jan K ^a   Kanniainen, Charlene M ^a   Hoglin, J Adele ^a   Robison, Tom S ^a   Zumhofe, Jeff M ^a  

^a 3M COMPANY   (United States)

Author keywords

1,2 dinitroglycerin; 1,3 dinitroglycerin; bioequivalence; nitroglycerin; transdermal delivery

Indexed keywords

GLYCERYL TRINITRATE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG FORMULATION; FLUSHING; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; SKIN PENETRATION; TRANSDERMAL DRUG ADMINISTRATION; VERTIGO;

EID: 0029907941     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-199608000-00006     Document Type: Article

References (16)

1. Baker RW, Farrant J: Patents in drug delivery. Pharm. Technol. The Latest Developments in Drug Delivery Systems: 1987 Conference Proceedings: 26-31.
2. Chien YW: Pharmaceutical considerations of transdermal nitroglycerin delivery: the various approaches. Am Heart J 1984;108:207-216.
3. Harrison LI, Riedel DJ: Transdermal nitroglycerin systems: methods for comparison. Clin Ther 1991;13:361-367.
4. Single-entity coronary vasodilators. Federal Register 1978; 43:41282-41285.
5. Nitroglycerin transdermal system; drug efficacy study implementation; revocation of exemption; final evaluation and announcement of marketing conditions. Federal Register 1993;58:38129-38132.
6. Williams RL, Thakker KM, John V, Lin ET, Liang-Gee W, Benet LZ: Nitroglycerin absorption from transdermal systems: formulation effects and metabolite concentrations. Pharmaceut Res 1991;8:744-749.
7. Sun JX, Piraino AJ, Morgan JM, Joshi JC, Chan K, John VA, Good WR: Application of a stable isotope technique for the bioequivalency study of two transdermal nitroglycerin systems. Am J Ther 1994;1:15-21.
8. Noonan PK, Gonzalez MA, Ruggierello D, Tomlinson J, Babcock-Atkinson E, Ray M, Golub A, Cohen A: Relative bioavailability of new transdermal nitroglycerin delivery system. J Pharmaceut Sci 1986;75:688-691.
9. Riedel DJ, Wick KA, Hawkinson RW, Kolars CA, Crowley JK, Armstrong KE, Chang SF, Harrison LI, de Dennis SRK: Performance of a new transdermal nitroglycerin adhesive patch formulation. Clin Ther 1989;11:225-231.
10. Todd PA, Goa KL, Langtry HD: Transdermal nitroglycerin (glyceryl trinitrate), a review of its pharmacology and therapeutic use. Drugs 1990;40:880-902.
11. Physician's Desk Reference, 49th ed. Medical Economics, Montvale, NJ, 1995, pp. 1216-1217, 1385-1386.
12. Wick KA, Wick SM, Hawkinson RW, Holtzman JL: Adhesion-to-skin performance of a new transdermal nitroglycerin adhesive patch. Clin Ther 1989;11:417-424.
13. Hougham AJ, Hawkinson RW, Crowley JK, Wilson RR, Glode JE, Hilty RW, Hughes SO, Koeppl CG, Kovaric TR, Wyskoarko NP: Improved skin adherence and patient acceptance in a new transdermal nitroglycerin delivery system. Clin Ther 1989;11:23-31.
14. Bogaert MG, Rossel MT, De Schaepdryver AF: Cardiovascular effects of glyceryldinitrates as compared to glyceryltrinitrate. Arch Int Pharmacodyn 1968;176:458-460.
15. Noonan PK, Benet LZ: Variable glycerol dinitrate formation as a function of route of nitroglycerin administration. Clin Pharmacol Ther 1987;42:273-277.
16. Sun JX, Piraino AJ, Morgan JM, Joshi JC, Cipriano A, Chan K, Redalieu E: Comparative pharmacokinetics and bioavailability of nitroglycerin and its metabolites from Transderm-Nitro, Nitrodisc, and Nitro-Durr II systems using a stable-isotope technique. J Clin Pharmacol 1995; 35:390-397.